1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide

C100H99F12N15O12 — CID 161008582

IUPAC1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide
SMILESCCn1cc(C(=O)Nc2ccc(C)c(-c3cc(N4CCOCC4)c(=O)n(C)c3)c2)cc(C(F)(F)F)c1=O.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)c1.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(NCCO)nc(N2CCOCC2)c1.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cncc(N2CCOCC2)n1
InChIInChI=1S/C26H27F3N4O4.C26H27F3N4O3.C25H24F3N3O3.C23H21F3N4O2/c1-4-32-15-18(11-21(24(32)35)26(27,28)29)23(34)30-19-6-5-16(2)20(13-19)17-12-22(25(36)31(3)14-17)33-7-9-37-10-8-33;1-17-5-6-21(31-25(35)18-3-2-4-20(13-18)26(27,28)29)16-22(17)19-14-23(30-7-10-34)32-24(15-19)33-8-11-36-12-9-33;1-16-6-7-20(29-23(32)17-4-3-5-19(12-17)25(26,27)28)14-21(16)18-13-22(24(33)30(2)15-18)31-8-10-34-11-9-31;1-15-5-6-18(28-22(31)16-3-2-4-17(11-16)23(24,25)26)12-19(15)20-13-27-14-21(29-20)30-7-9-32-10-8-30/h5-6,11-15H,4,7-10H2,1-3H3,(H,30,34);2-6,13-16,34H,7-12H2,1H3,(H,30,32)(H,31,35);3-7,12-15H,8-11H2,1-2H3,(H,29,32);2-6,11-14H,7-10H2,1H3,(H,28,31)
InChIKeyTWVGQSXLYXDYBE-UHFFFAOYSA-N
MW1930.96 g/mol
LogP17.25
Rot. Bonds20

About 1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide

1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide (PubChem CID 161008582) has the molecular formula C100H99F12N15O12 and a molecular weight of 1930.96 g/mol. Its IUPAC name is 1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide.

Molecular Properties

Compound Name1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide
PubChem CID161008582
Molecular FormulaC100H99F12N15O12
Molecular Weight1930.96 g/mol
Exact Mass1929.74
IUPAC Name1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide
SMILESCCn1cc(C(=O)Nc2ccc(C)c(-c3cc(N4CCOCC4)c(=O)n(C)c3)c2)cc(C(F)(F)F)c1=O.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)c1.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(NCCO)nc(N2CCOCC2)c1.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cncc(N2CCOCC2)n1
InChIInChI=1S/C26H27F3N4O4.C26H27F3N4O3.C25H24F3N3O3.C23H21F3N4O2/c1-4-32-15-18(11-21(24(32)35)26(27,28)29)23(34)30-19-6-5-16(2)20(13-19)17-12-22(25(36)31(3)14-17)33-7-9-37-10-8-33;1-17-5-6-21(31-25(35)18-3-2-4-20(13-18)26(27,28)29)16-22(17)19-14-23(30-7-10-34)32-24(15-19)33-8-11-36-12-9-33;1-16-6-7-20(29-23(32)17-4-3-5-19(12-17)25(26,27)28)14-21(16)18-13-22(24(33)30(2)15-18)31-8-10-34-11-9-31;1-15-5-6-18(28-22(31)16-3-2-4-17(11-16)23(24,25)26)12-19(15)20-13-27-14-21(29-20)30-7-9-32-10-8-30/h5-6,11-15H,4,7-10H2,1-3H3,(H,30,34);2-6,13-16,34H,7-12H2,1H3,(H,30,32)(H,31,35);3-7,12-15H,8-11H2,1-2H3,(H,29,32);2-6,11-14H,7-10H2,1H3,(H,28,31)
InChIKeyTWVGQSXLYXDYBE-UHFFFAOYSA-N
XLogP17.25
TPSA303.21 Ų
H-Bond Donors6
H-Bond Acceptors23
Rotatable Bonds20
Heavy Atoms139
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001930.96
LogP ≤ 517.25
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1023

Analyze 1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide?
The IUPAC name of 1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide (CID 161008582) is 1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide.
What is the SMILES notation for 1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide?
The canonical SMILES for 1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide is CCn1cc(C(=O)Nc2ccc(C)c(-c3cc(N4CCOCC4)c(=O)n(C)c3)c2)cc(C(F)(F)F)c1=O.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)c1.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(NCCO)nc(N2CCOCC2)c1.Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cncc(N2CCOCC2)n1.
What is the InChIKey of 1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide?
The InChIKey is TWVGQSXLYXDYBE-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H27F3N4O4.C26H27F3N4O3.C25H24F3N3O3.C23H21F3N4O2/c1-4-32-15-18(11-21(24(32)35)26(27,28)29)23(34)30-19-6-5-16(2)20(13-19)17-12-22(25(36)31(3)14-17)33-7-9-37-10-8-33;1-17-5-6-21(31-25(35)18-3-2-4-20(13-18)26(27,28)29)16-22(17)19-14-23(30-7-10-34)32-24(15-19)33-8-11-36-12-9-33;1-16-6-7-20(29-23(32)17-4-3-5-19(12-17)25(26,27)28)14-21(16)18-13-22(24(33)30(2)15-18)31-8-10-34-11-9-31;1-15-5-6-18(28-22(31)16-3-2-4-17(11-16)23(24,25)26)12-19(15)20-13-27-14-21(29-20)30-7-9-32-10-8-30/h5-6,11-15H,4,7-10H2,1-3H3,(H,30,34);2-6,13-16,34H,7-12H2,1H3,(H,30,32)(H,31,35);3-7,12-15H,8-11H2,1-2H3,(H,29,32);2-6,11-14H,7-10H2,1H3,(H,28,31).
What are the key properties of 1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide?
1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide has a molecular weight of 1930.96 g/mol, XLogP of 17.25, 20 rotatable bonds, 6 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 1-ethyl-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-6-oxo-5-(trifluoromethyl)pyridine-3-carboxamide;N-[3-[2-(2-hydroxyethylamino)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-(6-morpholin-4-ylpyrazin-2-yl)phenyl]-3-(trifluoromethyl)benzamide is sourced from PubChem (CID 161008582), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).